Matinas BioPharma Holdings (MTNB) Capital Leases (2014 - 2026)
Matinas BioPharma Holdings' Capital Leases was $5,000 in Q2 2026, down 54.5% from $11,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Capital Leases (2014 - 2026) Analysis & Trends
From Q1 2014 onward, Matinas BioPharma Holdings has reported Capital Leases for 42 quarters.
- Capital Leases has now declined for three consecutive years, with a five-year compound annual growth rate of -26.7% (FY2020 to FY2025).
- In earlier years, Capital Leases was $12,000 in FY2024 (-33.3%), $18,000 in FY2023 (-18.2%), $22,000 in FY2022 (+633.3%) and $3,000 in FY2021 (-87.3%).
- Quarterly Capital Leases has moved between $3,000 (Q4 2021) and $22,000 (Q4 2022) over five years.
- Compared with a year earlier, Capital Leases has declined for 11 straight quarters, with an average decline of 38.3% over the last eight quarters.
- The best year-over-year quarter for Capital Leases over five years was Q4 2022 (growth of 633.3%); the worst was Q4 2021 (a decline of 87.3%).
- Per Business Quant data, MTNB's Capital Leases in the three quarters before Q2 2026 was $5,000 (Q1 2026), $5,000 (Q4 2025) and $11,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Matinas BioPharma Holdings | 16.27 Mn | 3.68 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Dec 31, 2022 | 22,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 5,745.00 |
| Jun 30, 2021 | 11,508.00 |
| Mar 31, 2021 | 17,134.00 |
| Dec 31, 2020 | 23,660.00 |
API Access
Matinas BioPharma Holdings Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();